Press "Enter" to skip to content

Lupin launches generic seizure drug in US

As per IQVIA MAT March 2019 data, Clobazam tablets, in the two strengths, had an annual sales of around USD 479 million in the US, Lupin said.

Original source:

Also Read:   Prevagen maker must face FTC, New York claims that memory supplement does not work